Filter:
Industry:

Active

Cases

 
H

HOBA Therapeutics

Innovative biopharmaceuticals for patients with neuropathic pain

Unique Value Proposition

Development of the neurotrophic growth factors HB-086 and HB-097. The molecules constitute a unique family significantly differentiated from currently know neuronal growth factors. They both support neuroprotective and neuroregenerative functions and can improve quality of life for patients suffering from neuropathic pain and central nervous system disorders.

Business Model

Development and sale of products.

Stage

Proof of Technology

Links

www.hobatherapeutics.com

Information from virk.dk


HOBA Therapeutics
Ole Maaløes Vej 3, 2200 2200
3110 1285 · keap@hobatherapeutics.com
www.hobatherapeutics.com

CEO: Kenneth A. Petersen

Portfolio